COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

BACKGROUND: Patients with alpha-1 antitrypsin deficiency (AATD), commonly categorized as a rare disease, have been affected by the changes in healthcare management brought about by COVID-19. This study’s aim was to identify the changes that have taken place in AATD patient care as a result of the CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Calle Rubio, Myriam, López-Campos, José Luis, Miravitlles, Marc, Michel de la Rosa, Francisco Javier, Hernández Pérez, José María, Montero Martínez, Carmen, Montoro Ronsano, José Bruno, Casas Maldonado, Francisco, Rodríguez Hermosa, Juan Luis, Tabernero Huguet, Eva María, Martínez Sesmero, José Manuel, Martínez Rivera, Carlos, Callejas González, Francisco Javier, Torres Durán, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885054/
https://www.ncbi.nlm.nih.gov/pubmed/36717880
http://dx.doi.org/10.1186/s12913-023-09094-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885054/
https://www.ncbi.nlm.nih.gov/pubmed/36717880
http://dx.doi.org/10.1186/s12913-023-09094-3

Ejemplares similares